15 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 20023051 | Investigation of the involvement of P-glycoprotein and multidrug resistance-associated protein 2 in the efflux of ximelagatran and its metabolites by using short hairpin RNA knockdown in Caco-2 cells. | 2010 Mar | 1 |
2 | 20621639 | Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays. | 2010 Sep 11 | 2 |
3 | 20724802 | Inhibition of P-glycoprotein-mediated efflux of digoxin and its metabolites by macrolide antibiotics. | 2010 | 2 |
4 | 20977453 | Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1. | 2010 Nov | 2 |
5 | 18703021 | Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84). | 2008 Oct 1 | 1 |
6 | 18928592 | [Mechanism reversing MDR of K562/A02 by garlicin combined with erythromycin]. | 2008 Oct | 1 |
7 | 18027988 | Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. | 2007 | 1 |
8 | 16007523 | Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. | 2005 Aug 1 | 1 |
9 | 15543082 | Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux. | 2004 Nov-Dec | 3 |
10 | 15621665 | P-glycoprotein potentiates CYP3A4-mediated drug disappearance during Caco-2 intestinal secretory detoxification. | 2004 | 1 |
11 | 12909563 | Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test. | 2003 Sep | 2 |
12 | 12426516 | Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin. | 2002 Nov | 2 |
13 | 11724091 | Compound cardiac toxicity of oral erythromycin and verapamil. | 2001 Nov | 1 |
14 | 10783825 | P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. | 2000 Apr | 5 |
15 | 9822896 | Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. | 1998 Oct 9 | 5 |